We look at the clinical evidence GLP-1 receptor medication such as Ozempic (semaglutide), Semaglutide (semaglutide) , and Tirzepatide have transformed the landscape of obesity management and metabolic health
Method: Using hereditary angioedema (HAE) as an example, we demonstrate how this approach, supported by electronic medical records (EMRs), enables proactive care for patients with rare diseases
While serious liver damage from semaglutide is not a commonly recognized adverse effect, patients and healthcare providers should remain vigilant for signs and symptoms that could indicate hepatic dysfunction
Compounded medications, however, do not go through this specific FDA approval process for each individual batch
*Correspondence: Elizabeth A
Glucagon-Like Peptide 1 receptor agonists and risk of anaphylactic reaction among patients with Type 2 diabetes: a multisite population-based cohort study